Welcome to the english.simm.cas.cn!  
  About Us  
Brief Introduction   History
Address from the Director   Directors
Administration   Contact
  Research Divisions  
National Research Centers
State Key Laboratory of Drug Research
National Center for Drug Screening
National Engineering Laboratory for TCM Standardization Technology
Research Departments
Department of Medicinal Chemistry
Department of Natural Products Chemistry
Department of Pharmacology Ⅰ
Department of Pharmacology Ⅱ
Department of Pharmacology Ⅲ
Drug Discovery and Development Platforms
Drug Efficacy Evaluation Center
Drug Discovery and Design Center
Center for Drug Metabolism and Pharmacokinetics Research
Center for Drug Safety Evaluation and Research
Center for Drug Delivery Research
Research Center for Modernization of Traditional Chinese Medicine
Location: Home > Research Divisions > National Research Centers
Update time:
Text Size: A A A

  State Key Laboratory of Drug Research is affiliated to Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The laboratory completed its construction and got accreditation from Chinese government in 1995. Professor Jian Ding is the current director of the laboratory and Professor Kai-Xian Chen is the chairman of the academic committee of the laboratory.

  The research priorities of the laboratory are the drugs to treat major diseases, such as cancers, neurodegenerative diseases, metabolic diseases and infectious diseases. Both the natural products and synthetic drugs are investigated by using the state-of-the-art theories and technologies in chemistry and biology. Chemical, pharmacological and toxicological studies are collaborated to discover the bioactive substances and to develop new drugs. Novel mechanisms underlying drug action are explored on molecular, cellular and whole animal levels. Novel theories and innovative technologies for drug discovery are investigated.

  There are 40 research personnel in the laboratory, including 3 members of Chinese Academy of Sciences and Chinese Academy of Engineering, 8 Outstanding Youth, 11 talents ofCAS Hundred Talents Project and 4 chief scientists of 973 Program. The recent achievements include Depsides Salt, a modernized TCM, for the treatment of coronary artery disease and Antofloxacin Hydrochloride, an anti-bacterial drug. Several compounds, such as Schiprine (anti-Alzheimer disease), Salvicine (anti-cancer) and Sulcardine Sulfate (anti-arrhythmia) are under clinical trials. Another 13 drug candidates are in preclinical studies.

  In the national evaluation held in 2001 and 2006, the laboratory was listed in the top 6 and top 5 among nearly 60 key labs in the field of life sciences. Due to its research achievements and outstanding management, the laboratory was awarded in 2004 with a golden bull medal and certificate by Ministry of Science and Technology.

CopyRight © Shanghai Institute of Materia Medica,Chinese Academy of Sciences.